vs

Side-by-side financial comparison of APTARGROUP, INC. (ATR) and Vestis Corp (VSTS). Click either name above to swap in a different company.

APTARGROUP, INC. is the larger business by last-quarter revenue ($962.7M vs $663.4M, roughly 1.5× Vestis Corp). APTARGROUP, INC. runs the higher net margin — 7.7% vs -1.0%, a 8.7% gap on every dollar of revenue. On growth, APTARGROUP, INC. posted the faster year-over-year revenue change (13.5% vs -3.0%). APTARGROUP, INC. produced more free cash flow last quarter ($96.9M vs $28.3M). Over the past eight quarters, APTARGROUP, INC.'s revenue compounded faster (2.6% CAGR vs -3.0%).

AptarGroup, Inc., also known as Aptar, is a United States–based global manufacturer of consumer dispensing packaging and drug delivery devices. The group has manufacturing operations in 18 countries.

Vestis Corp is a leading provider of workplace uniforms, safety apparel, and facility service solutions. It primarily operates across North America, serving clients in healthcare, manufacturing, retail, hospitality, and public service sectors, offering customized uniform rental, cleaning, and maintenance programs tailored to varied business operational requirements.

ATR vs VSTS — Head-to-Head

Bigger by revenue
ATR
ATR
1.5× larger
ATR
$962.7M
$663.4M
VSTS
Growing faster (revenue YoY)
ATR
ATR
+16.5% gap
ATR
13.5%
-3.0%
VSTS
Higher net margin
ATR
ATR
8.7% more per $
ATR
7.7%
-1.0%
VSTS
More free cash flow
ATR
ATR
$68.6M more FCF
ATR
$96.9M
$28.3M
VSTS
Faster 2-yr revenue CAGR
ATR
ATR
Annualised
ATR
2.6%
-3.0%
VSTS

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
ATR
ATR
VSTS
VSTS
Revenue
$962.7M
$663.4M
Net Profit
$74.3M
$-6.4M
Gross Margin
Operating Margin
11.0%
2.5%
Net Margin
7.7%
-1.0%
Revenue YoY
13.5%
-3.0%
Net Profit YoY
-26.4%
-868.1%
EPS (diluted)
$1.13
$-0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ATR
ATR
VSTS
VSTS
Q1 26
$663.4M
Q4 25
$962.7M
$712.0M
Q3 25
$961.1M
Q2 25
$966.0M
$673.8M
Q1 25
$887.3M
$665.2M
Q4 24
$848.1M
$683.8M
Q3 24
$909.3M
$684.3M
Q2 24
$910.1M
$698.2M
Net Profit
ATR
ATR
VSTS
VSTS
Q1 26
$-6.4M
Q4 25
$74.3M
$-12.5M
Q3 25
$127.9M
Q2 25
$111.7M
$-676.0K
Q1 25
$78.8M
$-27.8M
Q4 24
$100.9M
$832.0K
Q3 24
$100.0M
$-2.3M
Q2 24
$90.5M
$5.0M
Operating Margin
ATR
ATR
VSTS
VSTS
Q1 26
2.5%
Q4 25
11.0%
2.5%
Q3 25
14.2%
Q2 25
14.9%
3.7%
Q1 25
12.8%
-1.3%
Q4 24
14.2%
4.4%
Q3 24
15.2%
4.4%
Q2 24
13.8%
5.4%
Net Margin
ATR
ATR
VSTS
VSTS
Q1 26
-1.0%
Q4 25
7.7%
-1.8%
Q3 25
13.3%
Q2 25
11.6%
-0.1%
Q1 25
8.9%
-4.2%
Q4 24
11.9%
0.1%
Q3 24
11.0%
-0.3%
Q2 24
9.9%
0.7%
EPS (diluted)
ATR
ATR
VSTS
VSTS
Q1 26
$-0.05
Q4 25
$1.13
$-0.10
Q3 25
$1.92
Q2 25
$1.67
$-0.01
Q1 25
$1.17
$-0.21
Q4 24
$1.48
$0.01
Q3 24
$1.48
$-0.02
Q2 24
$1.34
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ATR
ATR
VSTS
VSTS
Cash + ST InvestmentsLiquidity on hand
$409.5M
$41.5M
Total DebtLower is stronger
$1.1B
Stockholders' EquityBook value
$2.7B
$864.4M
Total Assets
$5.3B
$2.9B
Debt / EquityLower = less leverage
0.43×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ATR
ATR
VSTS
VSTS
Q1 26
$41.5M
Q4 25
$409.5M
$29.7M
Q3 25
$264.8M
Q2 25
$169.8M
$23.7M
Q1 25
$136.8M
$28.8M
Q4 24
$226.2M
$18.6M
Q3 24
$327.9M
$31.0M
Q2 24
$223.9M
$29.1M
Total Debt
ATR
ATR
VSTS
VSTS
Q1 26
Q4 25
$1.1B
$1.2B
Q3 25
$546.0M
Q2 25
$535.1M
Q1 25
$561.2M
Q4 24
$688.1M
Q3 24
$822.7M
$1.2B
Q2 24
$681.5M
Stockholders' Equity
ATR
ATR
VSTS
VSTS
Q1 26
$864.4M
Q4 25
$2.7B
$865.6M
Q3 25
$2.8B
Q2 25
$2.7B
$882.2M
Q1 25
$2.5B
$876.3M
Q4 24
$2.5B
$899.6M
Q3 24
$2.5B
$903.1M
Q2 24
$2.4B
$901.2M
Total Assets
ATR
ATR
VSTS
VSTS
Q1 26
$2.9B
Q4 25
$5.3B
$2.9B
Q3 25
$5.1B
Q2 25
$4.9B
$2.9B
Q1 25
$4.5B
$2.9B
Q4 24
$4.4B
$2.9B
Q3 24
$4.6B
$2.9B
Q2 24
$4.5B
$3.1B
Debt / Equity
ATR
ATR
VSTS
VSTS
Q1 26
Q4 25
0.43×
1.35×
Q3 25
0.20×
Q2 25
0.20×
Q1 25
0.22×
Q4 24
0.28×
Q3 24
0.32×
1.29×
Q2 24
0.28×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ATR
ATR
VSTS
VSTS
Operating Cash FlowLast quarter
$183.7M
$37.7M
Free Cash FlowOCF − Capex
$96.9M
$28.3M
FCF MarginFCF / Revenue
10.1%
4.3%
Capex IntensityCapex / Revenue
9.0%
1.4%
Cash ConversionOCF / Net Profit
2.47×
TTM Free Cash FlowTrailing 4 quarters
$299.6M
$45.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ATR
ATR
VSTS
VSTS
Q1 26
$37.7M
Q4 25
$183.7M
$30.9M
Q3 25
$177.6M
Q2 25
$126.0M
$22.9M
Q1 25
$82.7M
$6.7M
Q4 24
$178.2M
$3.8M
Q3 24
$229.3M
$295.6M
Q2 24
$143.6M
$48.7M
Free Cash Flow
ATR
ATR
VSTS
VSTS
Q1 26
$28.3M
Q4 25
$96.9M
$15.6M
Q3 25
$114.3M
Q2 25
$62.5M
$8.0M
Q1 25
$25.9M
$-6.9M
Q4 24
$112.2M
$-11.0M
Q3 24
$162.7M
$267.5M
Q2 24
$75.4M
$27.7M
FCF Margin
ATR
ATR
VSTS
VSTS
Q1 26
4.3%
Q4 25
10.1%
2.2%
Q3 25
11.9%
Q2 25
6.5%
1.2%
Q1 25
2.9%
-1.0%
Q4 24
13.2%
-1.6%
Q3 24
17.9%
39.1%
Q2 24
8.3%
4.0%
Capex Intensity
ATR
ATR
VSTS
VSTS
Q1 26
1.4%
Q4 25
9.0%
2.2%
Q3 25
6.6%
Q2 25
6.6%
2.2%
Q1 25
6.4%
2.0%
Q4 24
7.8%
2.2%
Q3 24
7.3%
4.1%
Q2 24
7.5%
3.0%
Cash Conversion
ATR
ATR
VSTS
VSTS
Q1 26
Q4 25
2.47×
Q3 25
1.39×
Q2 25
1.13×
Q1 25
1.05×
Q4 24
1.77×
4.54×
Q3 24
2.29×
Q2 24
1.59×
9.66×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ATR
ATR

Pharma Segment$833.1M87%
Other$129.6M13%

VSTS
VSTS

Workplace Supplies$375.2M57%
Uniforms$227.7M34%
Other$60.5M9%

Related Comparisons